[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370173-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370173-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","biometallic-ions-and-derivatives-a-new-direction-for-cancer-immunotherapy","Biometallic ions and derivatives - a new direction for cancer immunotherapy","","Biometallic ions play a crucial role in regulating the immune system and can address key limitations of current cancer immunotherapy. The review explains how zinc, copper, magnesium, manganese and related derivatives enhance immunotherapy by activating immune cells, improving tumor antigen presentation, and modulating the tumor microenvironment. It also discusses direct anti-tumor effects and the potential to reduce immunosuppressive signals. The article outlines role and future clinical prospects for metal-ion based therapeutic regimens.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/biometallic-ions-and-derivatives-a-new-direction-for-cancer-immunotherapy/370173/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/biometallic-ions-and-derivatives-a-new-direction-for-cancer-immunotherapy/370173.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do biometallic ions improve cancer immunotherapy effectiveness?","Question",{"text":63,"@type":64},"They enhance efficacy by activating immune cells, improving tumor antigen presentation, and modulating the tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What challenges in current cancer immunotherapy does the review highlight?",{"text":68,"@type":64},"Immune tolerance and immune escape, which can lead to resistance and treatment failure, along with side effects that require prompt management.",{"name":70,"@type":61,"acceptedAnswer":71},"What future application prospects does the review propose for biometallic ions?",{"text":72,"@type":64},"It explores their role and potential clinical use as part of cancer immunotherapy, aiming to guide development of more effective and safer treatment regimens.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370173,1790543159,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Zhao et al. Molecular Cancer (2025) 24:17 [https://doi.org/10.1186/s12943-025-02225-w](https://doi.org/10.1186/s12943-025-02225-w)  \nMolecular Cancer  \nREVIEW Open Access  \nBiometallic ions and derivatives: a new direction for cancer immunotherapy  \nLin Zhao 1,2, Yajun Gui 1,2, Jing Cai 1,2 and Xiangying Deng 1,2,3*  \nAbstract  \nBiometallic ions play a crucial role in regulating the immune system. In recent years, cancer immunotherapy has become a breakthrough in cancer treatment, achieving good efficacy in a wide range of cancers with its specificity and durability advantages. However, existing therapies still face challenges, such as immune tolerance and immune escape. Biometallic ions (e. g. zinc, copper, magnesium, manganese, etc.) can assist in enhancing the efficacy of immunotherapy through the activation of immune cells, enhancement of tumor antigen presentation, and improvement of the tumor microenvironment. In addition, biometallic ions and derivatives can directly inhibit tumor cell progression and offer the possibility of effectively overcoming the limitations of current cancer immunotherapy by promoting immune responses and reducing immunosuppressive signals. This review explores the role and potential application prospects of biometallic ions in cancer immunotherapy, providing new ideas for future clinical application of metal ions as part of cancer immunotherapy and helping to guide the development of more effective and safe therapeutic regimens.  \nKeywords Metal loimmunology, Biometallic ions, Metal materials, Cancer immunotherapy  \nIntroduction  \nCancer immunotherapy has been one of the major breakthroughs in cancer treatment in recent years, and its importance and status have attracted much attention [1, 2]. The importance of immunotherapy lies in its unique mechanism of action. Immunotherapy can activate the patient’s innate immune system, enabling it to attack and destroy cancer cells. With better specificity and fewer side effects than traditional treatments have, immunotherapy can more accurately identify and attack  \n*Correspondence:  \nXiangying Deng  \n[DXY1990@csu.edu.cn](DXY1990@csu.edu.cn)  \n1Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 41001l, China  \n2Hunan Clinical Medical Research Center for Cancer Pathogenic Genes Testing and Diagnosis, Changsha, Human 410011, China  \n3Institute of Medical Sciences, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China  \ncancer cells, thereby reducing damage to normal cells. In addition, immunotherapy has the advantage of durability: Some treatments stimulate the establishment of long-term immune memory, allowing the immune system to recognize and attack cancer cells over the long term and thus reducing the rate of cancer recurrence. Immunotherapy has now become an important part of the treatment regimen for a variety of cancers, including malignant melanoma [3], non-small cell lung cancer [4], uroepithelial carcinoma [5], colorectal cancer [6] and Hodgkin’s lymphoma [7].  \nThe main approaches to cancer immunotherapy include immune checkpoint inhibitors [8], CAR-T-cell therapy [9] and tumor vaccines [10]. On the one hand, immune checkpoint inhibitors restore the immune system’s attack on cancer cells by blocking the T-cell immunosuppressive pathway, while CAR-T cell therapy works by modifying the patient’s T-cells so that they can specifically recognize and attack cancer cells. On the other  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have pe","cbCaiieHushRTKf3","https://ap.wps.com/l/cbCaiieHushRTKf3","pdf",2376237,25,"English","# Abstract\n# Introduction","[{\"question\":\"How do biometallic ions improve cancer immunotherapy effectiveness?\",\"answer\":\"They enhance efficacy by activating immune cells, improving tumor antigen presentation, and modulating the tumor microenvironment.\"},{\"question\":\"What challenges in current cancer immunotherapy does the review highlight?\",\"answer\":\"Immune tolerance and immune escape, which can lead to resistance and treatment failure, along with side effects that require prompt management.\"},{\"question\":\"What future application prospects does the review propose for biometallic ions?\",\"answer\":\"It explores their role and potential clinical use as part of cancer immunotherapy, aiming to guide development of more effective and safer treatment regimens.\"}]","Biometallic ions and derivatives - a new direction for cancer immunotherapy | PDF",1790187152,63,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ed123e311d1e8810bfb90eea9d221a2.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8890ffafd1f430ac6f0282f21b24b829.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5a8f867344624a1c39a27dc9f847364.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/056c07d5650ed0f212022e942768e686.webp",980,1306]